A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
about
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data reviewOutcomes of sustained-release formulation of valproate and topiramate monotherapy in patients with epilepsy: a multi-centre, cohort studyTopiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.Cognitive Effects of Low-dose Topiramate Compared with Oxcarbazepine in Epilepsy PatientsReview of topiramate for the treatment of epilepsy in elderly patients.Pharmacotherapy for treatment-resistant schizophrenia.Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009.A muliticenter retrospective study of the actual using patterns and clinical effects of topiramate in patients with neurosurgical diseaseReview of new antiepileptic drugs as initial therapy.New drugs for the treatment of epilepsy: a practical approachPharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers.The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs.Topiramate and its clinical applications in epilepsy.Topiramate in the treatment of partial and generalized epilepsy.Use of second-generation antiepileptic drugs in the pediatric population.Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions.Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.Pharmacotherapy of focal epilepsy in children: a systematic review of approved agents.Weight change, genetics and antiepileptic drugs.The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy.Topiramate for Treatment in Patients With Migraine and Epilepsy.Long-term assessment of topiramate for epilepsy: an open-label, single-arm, multicentre, prospective study in a naturalistic setting.Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.Opinion of Belgian neurologists on antiepileptic drug treatment in 2006: Belgian study on epilepsy treatment (BESET-2).Topiramate: potential trade-offs between efficacy and tolerability in the treatment of epilepsy.Daytime sleepiness in epilepsy patients receiving topiramate monotherapy.Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy.Topiramate in long-term treatment of epilepsy in the intellectually disabled.Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study.Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine.Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate.Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study.Epilepsy outcomes in elderly treated with topiramate.
P2860
Q24186683-8C2F40CB-67EB-41A7-A8C5-4CBA873ECC25Q28484278-67268253-151F-4815-90AD-E3C07860C238Q31147165-82210024-DFA7-468F-956D-1F8DD808FA15Q33202108-1FC9C0DD-C5EA-43A7-860B-332BD62F5335Q33252737-2C546ECC-A572-473C-8E91-CFD6F098C913Q33790784-7C2900B9-5D77-49EA-8AD4-A7643C368E30Q33819386-5A23C57A-E7FE-44DB-93A9-9E43BB98077BQ34879109-14968A49-AFB6-454C-B020-E8EBCB1A599FQ34965263-1A09F363-9752-4936-894D-54FEE8A01FFDQ34965369-BFACD1A1-9395-4269-8E6F-1FF03E6BF87CQ35161324-285DCB78-24F2-451D-9D81-334E2A24516CQ35520425-88937306-9C88-4D13-9A11-36D44991D707Q35557445-AB2CAD03-5E1F-4FC6-94BE-A53E32D038C5Q36178890-344D39E5-741C-43C0-9143-B845F6CEFF40Q36429751-C932B22C-641B-459C-9F7F-B1AA071AD66DQ37129817-26618C47-AC84-4A68-BBFE-F39488F312E0Q37203259-AB2EAE4E-6FF2-4458-9711-FC2D230D8FB0Q37288805-C89E311F-CFF4-4901-AF9F-384414659D41Q38076740-A08C17B5-9D0A-4C72-9EAD-19B2A31338EBQ38091652-9B405F64-6103-4D88-8E32-A0D8BB3CE695Q38168942-1D8F8F06-BFF1-43CD-8546-75F9C9DA7300Q38505575-0D450EEE-B989-4553-97D4-8CACD04C9546Q38819478-A9613A33-1D40-4B11-AC64-9DB7835F4158Q42618672-6F057BC9-C091-44E5-9BAD-43B197A90052Q42873615-8C3B09EF-78A6-4B1B-A5FA-6255EC022A08Q42969571-126FAA77-306B-493B-8F62-2F6CC8960D21Q43266991-C33A6374-817B-447B-A209-C889E7C2FCBCQ44550128-9F39CAAA-8C00-40A6-B50A-86BE8C020EEEQ44805063-BC56A48C-8B59-40FF-8368-D4FE02A02C3FQ44835752-6E09ADCA-CFDA-4E82-942F-FF8C2478B1B6Q45266638-1B8C759E-A749-4794-A6E8-E7F60018F983Q45810988-65769D8C-7445-4EA6-9F7C-0FF00F67F93EQ46016262-58278299-8225-495E-8F94-137B9CCE0215Q46169270-A8841096-8AFE-4D41-ABA5-5759E1127E39Q46248484-56B3C81E-139E-4E14-B616-FD1061EB15C8Q46298140-6F5129AF-548F-4B41-9CAD-C109B2DDF810Q46460384-5AACABB2-BE97-46AA-B075-9D3B5F9C0113Q46505592-B1348C74-4C80-454E-9B5B-3135485C6B13Q46583639-95ECC363-2406-4D3F-AD9B-D35FB49F21BCQ46667915-5F9417D2-6F72-4317-A069-90D1022299BA
P2860
A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A dose-comparison trial of top ...... ly diagnosed partial epilepsy.
@en
A dose-comparison trial of top ...... ly diagnosed partial epilepsy.
@nl
type
label
A dose-comparison trial of top ...... ly diagnosed partial epilepsy.
@en
A dose-comparison trial of top ...... ly diagnosed partial epilepsy.
@nl
prefLabel
A dose-comparison trial of top ...... ly diagnosed partial epilepsy.
@en
A dose-comparison trial of top ...... ly diagnosed partial epilepsy.
@nl
P2093
P1433
P1476
A dose-comparison trial of top ...... ly diagnosed partial epilepsy.
@en
P2093
F G Gilliam
J P Ter Bruggen
M A M Bomhof
P304
P356
10.1212/01.WNL.0000048200.12663.BC
P407
P577
2003-01-01T00:00:00Z